On Feb. 21, 2023, Gilead Sciences announced positive data from three retrospective real-world studies which demonstrated that initiation…
On Feb. 16, 2023, National Institutes of Health (NIH) scientists announced they had developed and released an innovative…
On Feb. 15, 2023, Researchers from Southwest University in China have constructed the entire chromosomal-scale genome assembly and…
On Feb. 13, 2023, Equatorial Guinea today confirmed its first-ever outbreak of Marburg virus disease. Preliminary tests carried…
On Feb. 7, 2023, an NIH funded study by University of North Carolina reported that Bivalent booster vaccines…
On Feb. 7, 2023, the U.S. Department of Agricultureﾒs Research Service announced that it was implementing a $300…
On Feb. 2, 2023, a team of researchers supported by the National Institutes of Health found evidence linking…
On Feb. 1, 2023, researchers funded by the National Institutes of Health announded they had developed a new…
On Jan. 26, 2023, the U.S. Food and Drug Administration revised the Emergency Use Authorization for Evusheld (tixagevimab…
The Milestones in CRISPR cartoon illustrates several significant achievements in the development of the technology with commentary by…
On Jan. 18, 2023, researchers at the U.S. Department of Agriculture’s Agricultural Research Service announced they had bred…
On Jan. 13, 2023, a team of researchers including faculty at the Translational Genomics Research Institute (TGen), part…
On Jan. 11, 2023, the U.S. Food and Drug Administration reported that a single booster dose with an…
On Jan. 10, 2023, the WHO announced that an estimated 5 million children died beforecoronavirus_omicron_illustrationeir fifth birthday and…
On Jan. 9, 2023, BD (Becton, Dickinson) and CerTest Biotec have announced Emergency Use Authorization (EUA) from the…
On Jan. 5, 2023, BioNTech announced that the Company had signed a Memorandum of Understanding with the Government…
On Jan. 5, 2023, the National Institutes of Health, in collaboration with the Administration for Strategic Preparedness and…
On Jan. 5, 2023, National Institutes of Health researchers announded they had published an assessment of 13 studies…
On Jan. 4, 2023, a National Institutes of Health funded study reported that moderate levels of two outdoor…
Milestones in Polio illustrates the slow but steady advancements from its clinical description and discovery to widespread infection…
On Dec. 23, 2022, BioNTech and Fosun Pharmaceutical announced that they had received the certificates of registration as…
On Dec. 22, 2022, resarchers at the National Institutes of Health announced they had used patient stem cells…
On Dec. 21, 2022, the U.S. Department of Health and Human Services (HHS), through the Administration for Strategic…
On Dec. 21, 2022, Roche announced that the U.S. Food and Drug Administration (FDA) had approved Actemraﾮ (tocilizumab)…
On Dec. 20, 2022, the University of Oxford announced study results using data from 7 million people notified…
On Dec. 16, 2022, the U.S. Food and Drug Administration approved Ferring Pharmaceuticals’ Adstiladrin (nadofaragene firadenovec-vncg), a non-replicating…
On Dec. 14, 2022, the National Institutes of Health announced that two randomized, placebo-controlled trials evaluating three Ebola…
On Dec. 9, 2022, Washington University in St. Louis announced that it’s nasal COVID-19 vaccine technology had been…
On Dec. 8, 2022, the Department of Veterans Affairs embarked on a study to determine the most effective…
On Dec. 7, 2022, scientists reported in Nature an ancient environmental DNA (eDNA) record describing the rich plant…